文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Scent of a vaccine.

作者信息

Lund Frances E, Randall Troy D

机构信息

Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.

Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

出版信息

Science. 2021 Jul 23;373(6553):397-399. doi: 10.1126/science.abg9857.

DOI:10.1126/science.abg9857
PMID:34437109
Abstract
摘要

相似文献

[1]
Scent of a vaccine.

Science. 2021-7-23

[2]
Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.

Proc Natl Acad Sci U S A. 2022-6-14

[3]
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates.

Nat Immunol. 2024-10

[4]
Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques.

Nature. 2024-2

[5]
Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8 T cell responses.

Cell Rep Med. 2022-2-15

[6]
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.

Cell Host Microbe. 2021-2-10

[7]
Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses.

Science. 2022-11-25

[8]
The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity.

Front Immunol. 2021

[9]
Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection.

mBio. 2023-12-19

[10]
Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years.

JAMA. 2021-12-7

引用本文的文献

[1]
Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)-vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trial.

Sci Adv. 2025-7-4

[2]
Immunogenicity of RSV Fusion Protein Adsorbed to Non-Pathogenic Spores: Implications for Mucosal Vaccine Delivery in Nonclinical Animal Models.

Biomedicines. 2025-5-3

[3]
Laminar fluid ejection device enables high yield and preservation of mRNA and SaRNA LNP formulations.

Sci Rep. 2025-5-27

[4]
An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models.

Nat Commun. 2025-5-1

[5]
Effect of heterologous intranasal iNCOVACC vaccination as a booster to two-dose intramuscular Covid-19 vaccination series: a randomized phase 3 clinical trial.

Commun Med (Lond). 2025-4-23

[6]
Surface display of two neoantigens on Lactiplantibacillus plantarum.

Sci Rep. 2025-3-5

[7]
Progress in African Swine Fever Vector Vaccine Development.

Int J Mol Sci. 2025-1-22

[8]
SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development.

Vaccines (Basel). 2024-12-28

[9]
Antibodies as key mediators of protection against .

Front Immunol. 2024

[10]
Compartment-specific antibody correlates of protection to SARS-CoV-2 Omicron in macaques.

iScience. 2024-6-4

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索